Stock Events

Stock Events

Regencell Bioscience 

$24.41
0
-$4.12-14.44% Today

Statistics

Day High
25.66
Day Low
23.26
52W High
-
52W Low
-
Volume
20,151
Avg. Volume
-
Mkt Cap
12.07B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 17
$0.22
Sep 17
$0.22
Jun 17
$0.22
Mar 17
$0.22
Dec 16
$0.22
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-7.17MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RGC.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a cutting-edge area of biotechnology that overlaps with Regencell's focus on regenerative medicine, making them direct competitors in the biotech innovation space.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine operates in the genome editing field, directly competing with Regencell in the development of treatments for genetic diseases and conditions.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is a leading developer of CRISPR/Cas9 gene-editing therapies, competing with Regencell in the race to develop genetic treatments.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics specializes in genomic medicine, including gene therapy, competing with Regencell in the development of novel genetic treatments.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, competing with Regencell in the broader biotech market.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis and other serious diseases, competing with Regencell in the market for innovative therapeutic solutions.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals is a leader in RNAi (RNA interference) therapeutics, competing with Regencell in the field of genetic medicine.
Beam Therapeutics
BEAM
Mkt Cap2.53B
Beam Therapeutics focuses on precision genetic medicines using base editing, a form of gene editing, placing it in direct competition with Regencell's gene-based therapies.
Pfizer
PFE
Mkt Cap140.15B
Pfizer, a large pharmaceutical company, has been expanding its investment in biotechnology and gene therapy, making it a competitor to Regencell in the broader market for innovative treatments.

About

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Show more...
CEO
Mr. Yat-Gai Au
Employees
12
Country
KY
ISIN
KYG7487R1002

Listings

XNAS
US
RGC
BOATS
BOATS
RGC.BOATS

0 Comments

Share your thoughts

FAQ

What is Regencell Bioscience stock price today?▼
The current price of RGC.BOATS is $24.41 USD — it has decreased by -14.44% in the past 24 hours. Watch Regencell Bioscience stock price performance more closely on the chart.
What is Regencell Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Regencell Bioscience stocks are traded under the ticker RGC.BOATS.
What is Regencell Bioscience market cap?▼
Today Regencell Bioscience has the market capitalization of 12.07B
What is Regencell Bioscience revenue for the last year?▼
Regencell Bioscience revenue for the last year amounts to 0 USD.
What is Regencell Bioscience net income for the last year?▼
RGC.BOATS net income for the last year is -7.17M USD.
Does Regencell Bioscience pay dividends?▼
Yes, RGC.BOATS dividends are paid quarterly. The last dividend per share was 0.22 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Regencell Bioscience have?▼
As of February 02, 2026, the company has 12 employees.
In which sector is Regencell Bioscience located?▼
Regencell Bioscience operates in the Health Care sector.
When did Regencell Bioscience complete a stock split?▼
Regencell Bioscience has not had any recent stock splits.
Where is Regencell Bioscience headquartered?▼
Regencell Bioscience is headquartered in Causeway Bay, KY.